The Change of Subfoveal Choroidal Thickness After Intravitreal Injection of Ranibizumab and Its Correlation With Visual Acuity in Diabetic Retinopathy

This study focuses on understanding changes in a part of the eye called the choroid in people with diabetic retinopathy, a condition that affects vision in those with diabetes. The choroid is important because it supplies blood to the outer part of the retina. Researchers are interested in seeing how the thickness of the choroid changes after a specific eye injection called Ranibizumab, and how these changes relate to vision quality. Diabetic retinopathy can lead to vision loss, and this study aims to find better ways to monitor and potentially improve visual outcomes for these patients. Participants in the study receive an injection of Ranibizumab directly into the eye, a common treatment method for eye conditions. To measure the effects of this treatment, researchers use a technique called Optical Coherence Tomography (OCT), which takes detailed images of the eye. Enhanced Depth Imaging OCT allows for a closer look at the choroid to see how its thickness changes after the injection. Although the study does not list specific outcomes, the focus is on understanding how these changes might impact vision, potentially leading to improved treatments for diabetic eye disease.